Geode Capital Management LLC Sells 67,567 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Geode Capital Management LLC lessened its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 1.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,547,828 shares of the medical instruments supplier's stock after selling 67,567 shares during the quarter. Geode Capital Management LLC owned about 1.78% of DENTSPLY SIRONA worth $96,028,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of XRAY. First Eagle Investment Management LLC raised its position in shares of DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier's stock valued at $325,571,000 after buying an additional 3,283,965 shares in the last quarter. Dimensional Fund Advisors LP raised its position in DENTSPLY SIRONA by 42.0% during the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier's stock valued at $110,118,000 after purchasing an additional 1,308,411 shares in the last quarter. Cooke & Bieler LP raised its position in DENTSPLY SIRONA by 16.2% during the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier's stock valued at $186,996,000 after purchasing an additional 1,046,105 shares in the last quarter. Invenomic Capital Management LP bought a new stake in DENTSPLY SIRONA during the third quarter worth $23,724,000. Finally, National Bank of Canada FI boosted its holdings in shares of DENTSPLY SIRONA by 684.6% in the 2nd quarter. National Bank of Canada FI now owns 876,400 shares of the medical instruments supplier's stock valued at $21,586,000 after purchasing an additional 764,700 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

Analysts Set New Price Targets

XRAY has been the subject of several recent analyst reports. UBS Group dropped their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research report on Tuesday, December 3rd. Morgan Stanley dropped their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a report on Tuesday. Leerink Partners lowered shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Robert W. Baird lowered their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating for the company in a research report on Friday, November 8th. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, DENTSPLY SIRONA currently has an average rating of "Hold" and a consensus target price of $27.91.

DENTSPLY SIRONA Trading Down 1.1 %

XRAY traded down $0.21 during midday trading on Thursday, hitting $18.47. 3,064,918 shares of the company were exchanged, compared to its average volume of 3,099,693. The firm has a market capitalization of $3.67 billion, a P/E ratio of -8.92, a P/E/G ratio of 1.93 and a beta of 0.96. The firm's 50 day moving average price is $20.96 and its 200-day moving average price is $24.01. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 1-year low of $17.21 and a 1-year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm's quarterly revenue was up .4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.49 earnings per share. As a group, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 3.47%. The ex-dividend date is Friday, December 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -30.92%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.